← back to search

Tom Hunter

Amgen (United States) · US

Area of research

Nephrology · Endocrinology, Diabetes and Metabolism

Research interest

Research interests include Parathyroid Disorders and Treatments, Growth Hormone and Insulin-like Growth Factors, Hypothalamic control of reproductive hormones, and Magnesium in Health and Disease.

h-index

2

citations

173

works

2

NIH funding

—

primary concept

—

email

✉ Find email ↗

Recent publications

Pharmacology of AMG 416 (Velcalcetide), a Novel Peptide Agonist of the Calcium-Sensing Receptor, for the Treatment of Secondary Hyperparathyroidism in Hemodialysis Patients

Journal of Pharmacology and Experimental Therapeutics 2013cited by 111position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Randolph M. Johnson · Portola Pharmaceuticals (United States)1 papers (2013–2013)Derek Maclean · Southampton General Hospital1 papers (2013–2013)Gregory Bell · University of California, San Francisco1 papers (2013–2013)Qun Yin · SAIC-GM (China)1 papers (2013–2013)Felix Karim · Amgen (United States)1 papers (2013–2013)Amos Baruch · Enzo Life Sciences (United States)1 papers (2013–2013)Shawn T. Alexander · Amgen (United States)1 papers (2013–2013)James Tomlinson · Sheffield Teaching Hospitals NHS Foundation Trust1 papers (2013–2013)Julie Janes · Dana-Farber Cancer Institute1 papers (2013–2013)Sarah Walter · University of Southern California1 papers (2013–2013)Jin Dong · AstraZeneca (Australia)1 papers (2013–2013)Dirk B. Mendel · Spark Therapeutics (United States)1 papers (2013–2013)